Literature DB >> 6090461

Isolation and characterization of thrombomodulin from human placenta.

H H Salem, I Maruyama, H Ishii, P W Majerus.   

Abstract

Protein C, a plasma protein, is activated by thrombin to a protease (protein Ca) that functions as a physiological anticoagulant. We have isolated thrombomodulin, a cofactor required for the rapid activation of protein C, from human placenta. The purification to near homogeneity was achieved using a crude Triton-solubilized protein fraction from a placental particulate fraction as starting material. Chromatography on DEAE-Sepharose removed 95% of the protein and achieved a 3-fold purification. Thrombomodulin was then isolated by affinity chromatography on a column of thrombin-Sepharose wherein the thrombin had been previously inactivated with diisopropyl fluorophosphate. The final preparation was purified 7,900-fold over the membrane extract with a yield of 7%. We obtained 0.88 mg of thrombomodulin from 100 g of membrane extract derived from 5 kg of placenta. The protein was nearly homogeneous as judged by electrophoresis on 10% acrylamide sodium dodecyl sulfate gels in the presence of 2-mercaptoethanol with an apparent Mr = 105,000. Western blot analysis without 2-mercaptoethanol gave an apparent Mr = 75,000. The protein stimulated the rate of protein C activation by thrombin 800-fold to 10 mol of Ca formed/min/mol of thrombin. Thrombin and thrombomodulin appear to form a 1:1 stoichiometric complex as judged from experiments where we measured the effect of varying the concentration of thrombomodulin with respect to thrombin and the converse, on rates of protein C activation. An antibody directed against rabbit lung thrombomodulin inhibited the human placenta protein by 66%, and the amino acid composition of the proteins from the two species was similar indicating that the proteins are closely related. The apparent Michaelis constant of the thrombin-thrombomodulin complex for protein C is 9.8 microM. The protein C activation reaction requires calcium ions and is maximal at 1 mM Ca2+; higher concentrations inhibited the reaction. Coagulation factor Va and factor Va light chain both stimulate the activity of human thrombomodulin 2- to 3-fold.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6090461

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Wandering through the laboratory.

Authors:  Philip W Majerus
Journal:  J Biol Chem       Date:  2010-12-17       Impact factor: 5.157

2.  Stability of the thrombin-thrombomodulin complex on the surface of endothelial cells from human saphenous vein or from the cell line EA.hy 926.

Authors:  A Beretz; J M Freyssinet; J Gauchy; D A Schmitt; C Klein-Soyer; C J Edgell; J P Cazenave
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

3.  Characterization of a thrombomodulin cDNA reveals structural similarity to the low density lipoprotein receptor.

Authors:  R W Jackman; D L Beeler; L VanDeWater; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Inhibition of activated protein C by platelets.

Authors:  S M Jane; C A Mitchell; L Hau; H H Salem
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

Review 5.  The haemostatic function of the vascular endothelial cell.

Authors:  H A Bull; S J Machin
Journal:  Blut       Date:  1987-08

Review 6.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

7.  Effect of thrombomodulin on the kinetics of the interaction of thrombin with substrates and inhibitors.

Authors:  J Hofsteenge; H Taguchi; S R Stone
Journal:  Biochem J       Date:  1986-07-01       Impact factor: 3.857

8.  Expression of thrombomodulin in astrocytomas of various malignancy and in gliotic and normal brains.

Authors:  M Maruno; T Yoshimine; T Isaka; R Kuroda; H Ishii; T Hayakawa
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 9.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

10.  Specificity of activated human protein C.

Authors:  S R Stone; J Hofsteenge
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.